Additional diagnostic value of MRI in patients with suspicious breast lesions based on ultrasound

Sarıca, Özgür; Uluc, Fatih

doi:10.1259/bjr.20140009

Cited by 18 publications

(9 citation statements)

References 35 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…According to Sarica & Uluc the sensitivity, specificity, NPV and PPV of MRI in BI-RADS III lesions were 94.2, 56.1, 90.7 and 68.1%, respectively When only sonomammograghy is used, the corresponding figures were as follows: 90.9, 56.7, 93.8 and 46.4% (24) .…”

Section: Discussionmentioning

confidence: 98%

Sonomammography versus MRI in Evaluation of BI-RADS III Breast Lesion

Helmy

2018

The Egyptian Journal of Hospital Medicine

View full text Add to dashboard Cite

Background: Breast cancer is sometimes found after symptoms appear, but many women with breast cancer have no symptoms. This is why regular breast cancer screening is so important, early detection and treatment are the most important strategies to prevent deaths from breast cancer. Breast cancer that's found early, when it's small and has not spread, is easier to treat successfully, regular screening tests are the most reliable way for early detection. Objective: to high light the role of sonomammography versus Magnetic Resonance Imaging (MRI) in evaluation of BI-RADS III (Breast Imaging Reporting and Data System) breast lesion. Patients and Methods: in this retrospective study, 28 patients with BI-RADS III breast lesion were assessed by Digital mammography (DM), Ultrasound (US) and MRI. The resultant images were correlated with reports of the pathology specimens. Results: histopathological analysis was done for each lesion with 13 lesions (46.43%) proved to be benign, 15 lesions (53.57%) proved to be malignant. The sensitivity, specificity, Positive predictive value (PPV) and Negative predictive value (NPV) of mammography (MG), ultrasonography and MRI in BI-RADS III breast lesions were calculated. Conclusion: BI-RADS III lesions group is a very critical group to deal with as it exhibits characters of both malignant and benign lesions. According to our study Dynamic contrast enhanced-Magnetic Resonance Imaging. (DCE-MRI) should go hand by hand with sonomammogaphy especially in BI-RADS III patients group, patients with benign looking lesion six months follow up is recommended and those with malignant looking lesion biopsy should be done.

show abstract

Section: Discussionmentioning

confidence: 98%

Sonomammography versus MRI in Evaluation of BI-RADS III Breast Lesion

Helmy

2018

The Egyptian Journal of Hospital Medicine

View full text Add to dashboard Cite

show abstract

Section: Accuracy Of Other Modalities For Breast Cancer Diagnosismentioning

confidence: 99%

“…MRI does not currently seem to be effective in ruling out the need for biopsy in the assessment of sonographic BI-RADS 4 lesions (Sarica and Uluc 2014). When only ultrasonographic BI-RADS 4 lesions are considered, the SP of MRI was 56.7% (Sarica and Uluc 2014). In meta-analysis, the SP of contrast-enhanced MRI in patients with breast lesions is 0.72 (Peters, et al 2008), and the pooled weighted SP of quantitative, diffusion- weighted (DW) MR imaging in patients with breast lesions was 0.84 (Chen, et al 2010).…”

Section: Accuracy Of Other Modalities For Breast Cancer Diagnosismentioning

confidence: 99%

Ultrasound Imaging Technologies for Breast Cancer Detection and Management: A Review

Guo

Qin

et al. 2018

Ultrasound in Medicine & Biology

305

199

View full text Add to dashboard Cite

Ultrasound imaging is a commonly used modality for breast cancer detection and diagnosis. In this review, we summarize ultrasound imaging technologies and their clinical applications for the management of breast cancer patients. The technologies include ultrasound elastography, contrast-enhanced ultrasound, 3-D ultrasound, automatic breast ultrasound and computer-aided detection of breast ultrasound. We summarize the study results seen in the literature and discuss their future directions. We also provide a review of ultrasound-guided, breast biopsy and the fusion of ultrasound with other imaging modalities, especially magnetic resonance imaging (MRI). For comparison, we also discuss the diagnostic performance of mammography, MRI, positron emission tomography and computed tomography for breast cancer diagnosis at the end of this review. New ultrasound imaging techniques, ultrasound-guided biopsy and the fusion of ultrasound with other modalities provide important tools for the management of breast patients.

show abstract

“…Worldwide, magnetic resonance imaging (MRI) of the breast is regarded as the most sensitive imaging technique for detecting breast cancer (1,2) . Although MRI has a very high sensitivity for detecting breast lesions, characterizing those lesions requires the interpretation of multiple images with a variety of contrasts (3) .…”

Section: Introductionmentioning

confidence: 99%

MRI Diagnostic Performance and Inter-Observer Agreement of Kaiser Score in The Assessment of Different Breast Lesions

Makboul

Farghaly²

2022

The Egyptian Journal of Hospital Medicine

View full text Add to dashboard Cite

Introduction: to evaluate Kaiser Score's diagnostic efficacy and inter-reader reliability and contrast it with the typical BI-RADS Lexicon.Materials and methods: This retrospective study included 100 participants with a total of 109 breast lesions, at Assiut University hospital in the period from January 2021 to June 2021. The fifth edition of the MRI BI-RADS Lexicon was used to determine the BI-RADS category for each lesion after two radiologists reviewed all MRI scans. Following the flowchart for the Kaiser Score, they were then categorized according to BI-RADS category assignments. Finally, a comparison of the Kaiser BI-RADS and score results with the MRI BI-RADS and histological data was made to assess the diagnostic accuracy and inter-observer agreement. Results: There was no noticeable difference between the Kaiser score and the BI-RADS, MRI BI-RADS, or the BI-RADS as the p-values for the diagnosis of all breast lesions, whether mass or NMEL, were 0.597, 0.84, and 0.495 respectively. The inter-observer agreement between Readers 1 and 2 in the diagnosis of all breast lesions, regardless of whether they were mass lesions or NMELs, using both Kaiser BI-RADS and MRI BI-RADS, was also significantly higher since the pvalue was less than 0.001. Conclusion: Kaiser score and MRI BI-RADS can be combined to enhance reader agreement and reduce experience-related variability. For readers with less experience, it can also be very helpful in making the diagnosis of doubtful and suspicious breast lesions.

show abstract

Additional diagnostic value of MRI in patients with suspicious breast lesions based on ultrasound

Cited by 18 publications

References 35 publications

Sonomammography versus MRI in Evaluation of BI-RADS III Breast Lesion

Sonomammography versus MRI in Evaluation of BI-RADS III Breast Lesion

Ultrasound Imaging Technologies for Breast Cancer Detection and Management: A Review

MRI Diagnostic Performance and Inter-Observer Agreement of Kaiser Score in The Assessment of Different Breast Lesions

Contact Info

Product

Resources

About